Your browser doesn't support javascript.
loading
Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis.
Richarz, Nina Anika; Puig, Luis; Pérez, Noelia; Cuadra-Urteaga, Jose; Elez, Elena; Fernández-Figueras, Maria Teresa.
Afiliación
  • Richarz NA; a Department of Dermatology , Hospital Universitari Germans Trias i Pujol , Badalona , Barcelona, Spain.
  • Puig L; b Universitat Autónoma de Barcelona (UAB) , Barcelona , Spain.
  • Pérez N; b Universitat Autónoma de Barcelona (UAB) , Barcelona , Spain.
  • Cuadra-Urteaga J; c Department of Dermatology , Hospital Santa Creu i Sant Pau , Barcelona , Spain.
  • Elez E; d Department of Pathology , Hospital Universitari General de Catalunya-QuirónSalud, Universitat Internacional de Catalunya , Sant Cugat del Vallés, Barcelona , Spain.
  • Fernández-Figueras MT; b Universitat Autónoma de Barcelona (UAB) , Barcelona , Spain.
Cancer Biol Ther ; 20(3): 237-239, 2019.
Article en En | MEDLINE | ID: mdl-30426827
ABSTRACT
Neutrophilic panniculitis is an infrequent but characteristic adverse event under therapy with BRAF inhibitors (BRAFi). Since the approval of vemurafenib for treatment of metastatic melanoma in 2011, only two cases of neutrophilic panniculitis in malignancies other than melanoma have been published. Histiocytoid infiltrates of immature neutrophils resembling histiocytes or myelocytes have been reported in Sweet's syndrome and rarely in other neutrophilic dermatoses. We describe a novel variant of neutrophilic panniculitis with histiocytoid myeloid cells in an early lesion from a patient treated with vemurafenib in combination with an anti-EGFR (epidermal growth factor receptor) agent for metastatic colon carcinoma, three weeks after initiation of therapy. Recognizing this variant of panniculitis associated to BRAFi can avoid misinterpretation of the atypical subcutaneous infiltrate as myeloid leukaemia cutis.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Paniculitis / Leucemia Mieloide / Vemurafenib / Antineoplásicos Límite: Humans / Male / Middle aged Idioma: En Revista: Cancer Biol Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2019 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Paniculitis / Leucemia Mieloide / Vemurafenib / Antineoplásicos Límite: Humans / Male / Middle aged Idioma: En Revista: Cancer Biol Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2019 Tipo del documento: Article País de afiliación: España